type-2

Documents about type-2

• A Research Study Looking at Long-term Blood Sugar Control in People With Type 2 Diabetes Being Treated With Xultophy® in a Real-world Setting in Italy#146372ClinicalTrials.gov
• Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic Drugs#158166ClinicalTrials.gov
• Comparison of the Blood Sugar Lowering Effect Between Repaglinide Plus Metformin and Repaglinide Alone in Type 2 Diabetics Not Previously Treated With Oral Sugar-lowering Drugs#158173ClinicalTrials.gov
• A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes#162427ClinicalTrials.gov
• Effect of Linagliptin in Comparison With Glimepiride as Add on to Metformin on Postprandial Beta Cell Function, Postprandial Metabolism and Oxidative Stress in Patients With Type 2 Diabetes Mellitus#180347ClinicalTrials.gov
• Specified Drug-Use Survey of Alogliptin and Metformin Hydrochloride Combination Tablets "Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Renal or Hepatic Impairment or Advanced Age"#181722ClinicalTrials.gov
• Vascular Effects of Sitagliptin in Diabetes Mellitus#28523ClinicalTrials.gov
• Phenotype Evaluation in Insulin Naive Patients Using Lantus (Insulin Glargine)#28529ClinicalTrials.gov
• iGlarLixi vs IDegAsp in Chinese Participants After OAD(s)#28569ClinicalTrials.gov
• The OBSTACLE Hypoglycemia Study (MK-0000-158)#67777ClinicalTrials.gov
• Glucose Reduction by Early Acarbose Treatment in Basal Insulin#123403ClinicalTrials.gov
• GALLANT 9 Tesaglitazar vs. Placebo in Combination With Insulin#126053ClinicalTrials.gov
• Diabetes Lifestyle Assessment and Educational Tools#127759ClinicalTrials.gov
• Acetylcarnitine and Insulin Sensitivity#143712ClinicalTrials.gov
• Reandron in Diabetic Men Witn Low Testosterone Level#143746ClinicalTrials.gov
• The Fructose and Allulose Catalytic Effects (FACE) Trial#146366ClinicalTrials.gov
• Glimepiride, Alogliptin and Alogliptin+Pioglitazone Combination#152351ClinicalTrials.gov
• LIraglutide and Beta-cell RepAir (LIBRA) Study#158134ClinicalTrials.gov
• Low dosE GlibENclamide in Diabetes Part A#158183ClinicalTrials.gov
• Study Evaluating Rimonabant Efficacy in Drug-NAive DiabEtic Patients#160270ClinicalTrials.gov
• IL-1RA, Acute Exercise, and Beta-cell Function#160282ClinicalTrials.gov
• Nutrition-Focused Approach During CGM Initiation: A Qualitative Study#172461ClinicalTrials.gov
• Comparing Efficacy and Safety of Thrice Daily Versus Twice Daily NovoMix® 30 (Biphasic Insulin Aspart 30) in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin#127847ClinicalTrials.gov
• Regulatory Post Marketing Surveillance (rPMS) Study of Rybelsus (Oral Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea#136217ClinicalTrials.gov
• A Clinical Trial to Examine the Efficacy and Safety of an Investigational Product With and Without Use of Semaglutide on Glycemic Response in Adults With Prediabetes or Type 2 Diabetes#146377ClinicalTrials.gov
• Addressing gender and social inequities: the challenge of metabolic control in women with type 2 diabetes in Quito#147595HAL (France)
• A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Bangladesh, Indonesia, Malaysia, Philippines, Sri Lanka and Vietnam#162318ClinicalTrials.gov
• Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and Sulfonylurea#162431ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin#180335ClinicalTrials.gov
• The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy#143802ClinicalTrials.gov
• Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 Diabetes#162363ClinicalTrials.gov
• Metabolic Effects of Pioglitazone in Type II Diabetic Patients Previously Treated With Insulin#67793ClinicalTrials.gov
• A Trial to Investigate the Efficacy and Safety of NW Low-Glu® in Patients With Type II Diabetes Mellitus#140946ClinicalTrials.gov
• Dose Finding Study of Il-2 at Ultra-low Dose in Children With Recently Diagnosed Type 1 Diabetes#184760ClinicalTrials.gov
• Changes in Mitochondrial Uncoupling Protein 2 (UCP2) Messenger RNA(mRNA) in Type 2 Diabetes (T2DM) Patients#123427ClinicalTrials.gov
• Charcot–Marie–Tooth type 2A variants of mitofusin 2 sensitize cells to apoptotic cell death#145046HAL (France)
• Efficacy vs Placebo as Initial Combination Therapy With Pioglitazone#18801ClinicalTrials.gov
• Effect of Metformin on Exercise-induced Lipolysis#28560ClinicalTrials.gov
• Evaluation of Insulin Glargine Versus Sitagliptin in Insulin-naive Patients#67835ClinicalTrials.gov
• Dexcom Continuous Glucose Monitoring in Long-term Care#121240ClinicalTrials.gov
• Vildagliptin/Metformin in T2DM Patients Starting Basal Insulin#123391ClinicalTrials.gov
• Levemir-Body Composition and Energy Metabolism#123424ClinicalTrials.gov
• Efficacy of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus#126044ClinicalTrials.gov
• Glycemic Evaluation of Novel Staple Foods#127755ClinicalTrials.gov
• Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis#127810ClinicalTrials.gov
• Network Service Header (NSH) Metadata Type 2 Variable-Length Context Headers#132338IETF RFCs
• Human Intestinal Peptides Evaluation and Research#136242ClinicalTrials.gov
• Developing Resiliency and Exercise Using AI-based Messaging#143740ClinicalTrials.gov
• Remote And Decentralised Innovative Approaches to Clinical Trials (RADIAL)#146340ClinicalTrials.gov
• Study of Renal Blood Flow During Human Endotoxemia#146359ClinicalTrials.gov